Agrochemicals firm Anupam Rasayan Indian announced Q3FY23 results: Q3FY23: Operating revenues at Rs 3,827 million in Q3FY23 as compared to Rs 2,662 million in Q3FY22 – growth of 44% YoY. Total revenues at Rs 3,888 million in Q3FY23 as compared to Rs 2,711 million in Q3FY22 – growth of 43% YoY. EBITDA (incl. other revenue) at Rs 1,080 million in Q3FY23 as compared to Rs 800 million in Q3FY22 – growth of 35% YoY. Profit After Tax at Rs 544 million in Q3FY23 as compared to Rs 379 million in Q3FY22 - growth of 44% YoY. Anand Desai, Managing Director of Anupam Rasayan, commented, “I am pleased to inform you that despite unavailability of the certain capacities during the quarter, we were able to deliver growth on YoY basis. If you adjust the deferred revenue due to capacity constrain then our growth would have been around 25% during the quarter. I am delighted to share that we have received approval to restart the plant from the GPCB and other regulatory authorities after following all the regulatory and safety compliances. This shows our unwavering focus on compliance and maintaining high levels of manufacturing and safety standards, which has helped us get the closure order lifted within a shorter time span. We continue to strengthen our business development team as we have a strong pipeline of products to launch in coming quarters. Our customer interactions remain very encouraging, and we have specifically seen strong interest from various customers on the fluorination side. Overall, our strong pipeline of products, availability of the capacity, advance stage discussion with various clients along with capex which is moving ahead of the plan makes me confident of delivering strong and sustainable growth in coming quarters and years.” Result PDF
Conference Call with Anupam Rasayan India Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.
Agrochemicals manufacturer Anupam Rasayan India announced Q2FY23 results: Standalone Q2FY23: Operating Revenues at Rs 3,107 million in Q2FY23 as compared to Rs 2,489 million in Q2FY22 – growth of 25% YoY. Total Revenues at Rs 3,087 million in Q2FY23 as compared to Rs 2,552 million in Q2FY22 – growth of 21% YoY. EBITDA (incl. other revenue) at Rs 898 million in Q2FY23 as compared to Rs 697 million in Q2FY22 – growth of 29% YoY. Profit After Tax at Rs 412 million in Q2FY23 as compared to Rs 358 million in Q2FY22 - growth of 15% YoY. Anand Desai, Managing Director of Anupam Rasayan, commented, “I am delighted to inform you that our standalone business grew by 25% year on year to Rs. 310 crore. with consistent EBITDA margins. Our philosophy of carrying a long-term vision in our business conduct is bearing its fruits as Anupam has started seeing the benefits of this Europe+1 trend with our latest announcement of signing two contracts with one of the European Crop Protection companies for supplying two new life science-related speciality chemicals. Overall, we continue to see upward bias in all the contracted volumes with major customers. This makes us confident of delivering a strong performance in the coming quarters and for the year.” Result PDF
Conference Call with Anupam Rasayan India Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.
Agrochemicals firm Anupam Rasayan India Announced Q1FY23 Result : Q1FY23 Operating Revenue of Rs 3,066 Mn; growth of 31.19% YoY Q1FY23 EBITDA at Rs 845 Mn; growth of 30.03% YoY Q1FY23 EBITDA Margin at 28.42%; up 113 bps YoY Operating Revenues at Rs 3,066 million in Q1FY23 as compared to Rs 2,337 million in Q1FY22 growth of 31% YoY. Total Revenues at Rs 2,971 million in Q1FY23 as compared to Rs 2,380 million in Q1FY22 growth of 25% YoY. EBITDA (incl. other revenue) at Rs 845 million in Q1FY23 as compared to Rs 650 million in Q1FY22 growth of 30% YoY Profit After Tax at Rs 397 million in Q1FY23 as compared to Rs 321 million in Q1FY22 growth of 24% YoY. Anand Desai, Managing Director of Anupam Rasayan, commented, “I am happy to inform you that, we delivered robust growth in Q1FY23 against the backdrop of an uncertain global environment. Our operating revenue grew by 31% on a year-on-year basis. Our focus on financial prudence and operational finesse has helped us keep our margins at sustainable levels. During the last financial year, our ability to ensure continuous supply to our customers has resulted in customers revising their volume guidance upwards for the current financial year along with the increase in price of these products. Tanfac integration is progressing smoothly with the successful integration of key areas like Finance, IT, and HR and I am happy to share that we have successfully expanded the capacity of certain Tanfac products with process improvement and debottlenecking. Overall, I believe we have an exciting year ahead of us and we at Anupam are all geared up to deliver strong sustainable growth in FY23.” Result PDF
Agrochemicals company Anupam Rasayan India announced Q4FY22 results: Q4FY22: Revenues at Rs 3,172 million in Q4FY22 as compared to Rs 2,717 million in Q4FY21 – growth of 17% YoY. EBITDA (incl. other revenue) at Rs 969 million in Q4FY22 as compared to Rs 655 million in Q4FY21 – growth of 48% YoY. Profit After Tax at Rs 461 million in Q4FY22 as compared to Rs 221 million in Q4FY21 - growth of 108% YoY. FY22: Revenues at Rs 10,660 million in FY22 as compared to Rs 8,109 million in FY21 – growth of 31% YoY EBITDA (incl. other revenue) at Rs 3,121 million in FY22 as compared to Rs 2,202 million in FY21 – growth of 42% YoY. Profit After Tax at Rs 1,522 million in FY22 as compared to Rs 703 million in FY21 – growth of 116% YoY. Anand Desai, Managing Director of Anupam Rasayan, commented, “I am pleased to announce that we have delivered a robust year registering a total revenue growth of 29%, mostly driven by a healthy volume ramp-up. With new LOIs getting signed and older ones getting converted into long-term contracts, the visibility for topline growth in the years to come becomes clearer. Further, our foray into Fluorination chemistries, which will drive our next phase of growth has been strengthened by our successful acquisition of Tanfac’s 26% stake. By the means of this acquisition, we look forward to backward integrate our supply chains in this vertical and focus on production of high value -high margin molecules that have application in varied industries which will give us impetus to enhance our margin profile.” Result PDF
Agrochemicals firm Anupam Rasayan India declares Q3FY22 result: Total Revenue of Rs 2,711 Mn; growth of 43% YoY Profit After Tax at Rs 379 Mn; growth of 75% Total Revenues at Rs 2,711 million in Q3FY22 as compared to Rs 1,896 million in Q3FY21 – growth of 43% YoY. EBITDA (incl. other revenue) at Rs 800 million in Q3FY22 as compared to Rs 588 million in Q3FY21 – growth of 36% YoY. Profit After Tax at Rs 379 million in Q3FY22 as compared to Rs 216 million in Q3FY21 - growth of 75% YoY Total Revenues at Rs 7,643 million in 9MFY22 as compared to Rs 5,632 million in 9MFY21 – growth of 36% YoY EBITDA (incl. other revenue) at Rs 2,152 million in 9MFY22 as compared to Rs 1,547 million in 9M FY21 growth of 39% YoY Profit After Tax at Rs 1,061 million in 9MFY22 as compared to Rs 482 million in 9MFY21 – growth of 120% YoY Anand Desai, Managing Director of Anupam Rasayan, commented, “I am pleased to announce that we have delivered a robust quarter registering a total revenue growth of 43% on a year-on-year basis, mostly driven by a healthy volume ramp-up. With new LOIs getting signed and older ones getting converted into long-term contracts, the visibility for top-line growth in the years to come becomes clearer.” He also added- “Growth in volumes, value re-engineering and internal efficiencies arising out of various initiatives such as commissioning of solar power plants, working capital reduction and backward integration from recently announced acquisition will all act as catalysts of sustained growth in the coming future” Result PDF
Conference Call with Anupam Rasayan India Ltd. Management and Analysts on its recent acquisition of Tanfac Industries. Listen to the full transcript.
Conference Call with Anupam Rasayan India Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.
Highlights: Q2 FY22: Total Revenues at Rs. 2,552 million in Q2 FY22 as compared to Rs. 2,390 million in Q2 FY21 – growth of 7% YoY. EBITDA (incl. other revenue) at Rs. 702 million in Q2 FY22 as compared to Rs. 636 million in Q2 FY21 – growth of 10% YoY. Profit After Tax at Rs. 361 million in Q2 FY22 as compared to Rs. 263 million in Q2 FY21 – growth of 37% YoY. Total debt of Rs. 5,630 Mn repaid as of Q2 FY22 from IPO proceeds. H1 FY22: Total Revenues at Rs. 4,931 million in H1 FY22 as compared to Rs. 3,736 million in H1 FY21 – growth of 32% YoY. EBITDA (incl. other revenue) at Rs. 1,352 million in H1 FY22 as compared to Rs. 959 million in H1 FY21 – growth of 41% YoY. Profit After Tax at Rs. 682 million in H1 FY22 as compared to Rs. 265 million in H1 FY21 – growth of 157% YoY. Anand Desai, Managing Director of Anupam Rasayan, commented, “Continuing the momentum further, I am pleased to announce that we have delivered yet another quarter and half year of increased profitability and strengthening balance sheet. Our margins along with metrics like client and geographic concentration have seen improvement even in midst of global raw material prices rising due to our inventory policy and cost-plus model. Our new molecule launches, new export orders, achievement of further debt reduction targets and commissioning of solar plant in Bharuch will give further impetus to our margins going forward. The prudent financial and capital rationing technique that we are sticking to is also helping us deliver sustained growth. I am also pleased to announce that we are at an advance stage to introduce a new molecule under electronic chemical segment, further we are working on various advanced niche molecules which are under pipeline at R&D; and pilot level which will be commercialized in coming quarters.” Result PDF